| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Director | Common Stock | 24.9K | $1.5M | $60.22 | May 1, 2025 | Direct |
| HALOZYME THERAPEUTICS, INC. | Director | Option to Purchase Common Stock | 5.75K | May 1, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| HALO | HALOZYME THERAPEUTICS, INC. | May 1, 2025 | 2 | $0 | 4 | May 2, 2025 | Director |
| HALO | HALOZYME THERAPEUTICS, INC. | Apr 25, 2024 | 2 | $0 | 4 | Apr 29, 2024 | Director |
| HALO | HALOZYME THERAPEUTICS, INC. | May 5, 2023 | 2 | $0 | 4 | May 9, 2023 | Director |
| HALO | HALOZYME THERAPEUTICS, INC. | May 5, 2022 | 1 | $0 | 4 | May 6, 2022 | Director |
| HALO | HALOZYME THERAPEUTICS, INC. | Mar 24, 2022 | 0 | $0 | 3 | Mar 24, 2022 | Director |